Acquiring Company
Bio-Rad Laboratories
Acquired Company
Stilla Technologies
HerculesManufacturingBiotechnologyLife ScienceBiotechnologySoftwareData And AnalyticsHealth CareScience And EngineeringDescription
Bio-Rad Laboratories has completed the acquisition of Stilla Technologies, a developer of droplet digital PCR technology. This acquisition is aimed at expanding Bio-Rad's Droplet Digital™ PCR offerings. The move underscores Bio-Rad's commitment to enhancing its product lineup. Stilla's innovative solutions will complement Bio-Rad's existing systems.
Quick answer
Bio-Rad Laboratories is acquiring Stilla Technologies, announced August 1, 2025. Bio-Rad Laboratories is based in Hercules, California, United States.
- How much did Bio-Rad Laboratories pay for Stilla Technologies?
- The deal value was not disclosed.
- What does Bio-Rad Laboratories do?
- Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics products, with a focus on developing, manufacturing, and marketing a broad range of products for the life science research..
- Where are Bio-Rad Laboratories and Stilla Technologies based?
- Bio-Rad Laboratories is based in Hercules, California, United States.
- Who are the decision-makers at Bio-Rad Laboratories?
- Fundz holds 3 contacts at Bio-Rad Laboratories. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Life Science and Data And Analytics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Avanos Medical acquires Nexus Medical for growth (September 15, 2025)
- Bausch Health acquires DURECT for $63M, $63M (September 11, 2025)
- Edwards Lifesciences acquires Vectorious for $497M, $497M (September 4, 2025)
- AbbVie completes acquisition of Capstan Therapeutics (August 19, 2025)
- Veralto acquires TraceGains to boost competitiveness (August 15, 2025)
- ESTEVE acquires Regis Technologies for U.S. expansion (July 31, 2025)
Who to call at Bio-Rad Laboratories, and when
When Bio-Rad Laboratories changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Bio-Rad Laboratories raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bio-Rad Laboratories, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bio-Rad Laboratories. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bio-Rad Laboratories makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Stilla Technologies?
Stilla Technologies was acquired by Bio-Rad Laboratories, based in Hercules. The deal was reported on August 1, 2025. Bio-Rad Laboratories, Inc. Bio-Rad Laboratories is publicly traded (BIO) and operates in Manufacturing.
When did Bio-Rad Laboratories acquire Stilla Technologies?
Bio-Rad Laboratories's acquisition of Stilla Technologies was reported on August 1, 2025. Bio-Rad Laboratories has completed the acquisition of Stilla Technologies, a developer of droplet digital PCR technology. This acquisition is aimed at expanding Bio-Rad's Droplet Digital™ PCR offerings. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Stilla Technologies do?
It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.